Celebrating 30 years


On the occasion of our 30 anniversary, from Europso, we decided to recognise the work of our members for the last years, arranging a gala dinner where some awards were shared with them.
The awards Gala dinner was headed by our Vice – President, David Trigos and Started with an opening speech of our President, Jan Koren. The celebration continued recognising the hard work of single people who made possible this 30 years.

EUROPSO 30 years summary

“Give Me My 3 Seconds” – EUROPSO

The EUROPSO Psoriasis Patient Study


Salonen S-H on behalf of the EUROPSO Patient Survey Study Group EUROPSO, Helsinki, Finland


Psoriasis can have a profound impact on a person’s quality of life, particularly if it is extensive, affects a visible or sensitive area, or is difficult to treat. To explore the impact of psoriasis on the quality of life of European patients and to learn about patients’ perceptions of current treatments, EUROPSO (European Federation of Psoriasis Patient Organisations) has conducted a large-scale postal survey of the members of nine European patient associations …


OpenLetter Value of Health Cooperation

EU Health Collaboration is crucial for Europe’s future

Dear President Juncker,
We, the undersigned organisations, repre senting EU health stakeholders, wish to express our grave concern about the future of health in European policies and programmes, in the light of your White Paper on the Future of Europe, and propose an urgent meeting with you and your services on this topic.
Our determined view, shared by the vast majority of EU citizens, is that health is absolutely and unequivocally a core business of the EU. Protection of a high level of human health and wellbeing is entrenched in the Treaties of the European Union.
1 EU collaboration in the field of health is indispensable for the future of Europe and rebuilding the trust of citizens in the European Union. We need more health to unlock the full potential of economic and social policies. 70% of Europeans want the EU to do more for health, according to the most recent Eurobarometer survey. With such a strong, unequivocal demand from EU citizens for more action in the field of health, it is essential that this is not only maintained, but actually enhanced. The EU needs to continue de liver results that make a tangible difference in the daily lives of its citizens and thus re-establish people’s trust in its institutions.

EADV Cleara about Psoriasis

Patients with moderate-to-severe psoriasis do not believe clearance of their skin is a realistic treatment goal: results from the largest global psoriasis patient survey

Warren R.B.(1), Armstrong A.(2), Boehncke W-H.(3), Fernández-Peñas P.(4), Bewley A.(5), Romiti R.(6), Rajagopalan M.(7), Jarvis S.(8), Hillmann O.(9), Boyd E.(10), Sodha M.(11), Vaid B.(12), Huneault L.(13), Fox T.(14)

(1)The Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, The University of Manchester, United Kingdom, (2)Department of Dermatology, Keck School of Medicine at USC, University of Southern California, Los Angeles, United States, (3)Geneva University Hospital, Division of Dermatology and Venerology, Department of Internal Medicine Specialities, Geneva, Switzerland, (4)The University of Sydney, Westmead Hospital, Department of Dermatology, Westmead, Australia, (5)Whipps Cross University Hospital and The Royal London Hospital, Department of Dermatology, London, United Kingdom, (6)Department of Dermatology, University of São Paulo, Brazil, (7)Apollo Hospitals, Department of Dermatology, Chennai, India, (8)Richford Gate Medical Practice, London, United Kingdom, (9)EUROPSO, Düsseldorf, Germany, (10)National Psoriasis Foundation, VP Strategic Alliances and Clinical Affairs, Portland, United States of America, (11)GfK, Basel, Switzerland, (12)Novartis Pharma AG, Communications, Basel, Switzerland, (13)Novartis Pharma AG, Public Relations, Basel, Switzerland, (14)Novartis Pharma AG, Basel, Switzerland